On Friday 24 April, WHO, heads of state, international institutions, philanthropic leaders and private actors announced the launch of the ‘Access to COVID-19 Tools (ACT) Accelerator’ to secure access to COVID-19 medical products. A lot of good declarations were made which raised a lot of questions on how they will be implemented and how equitable access will be guaranteed. The ACT Accelerator launch pre-empted an EU pledging conference which will be held on Monday 4 May and is intended to begin the process of securing financing (with an aim of securing 8 billion euros) for COVID-19 R&D. The ‘how’ has not yet been worked out and the ACT Accelerator only consists of good principles, for now. They are inviting more input from stakeholders.